A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir

Antivir Ther. 2003 Dec;8(6):507-18.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / virology
  • Adenine / administration & dosage
  • Adenine / analogs & derivatives*
  • Adult
  • Alkynes
  • Benzoxazines
  • Cyclopropanes
  • Dideoxynucleosides / administration & dosage
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Genotype
  • HIV-1* / drug effects
  • HIV-1* / genetics
  • Humans
  • Indinavir / therapeutic use
  • Male
  • Nelfinavir / administration & dosage
  • Organophosphonates*
  • Oxazines / administration & dosage
  • Phenotype
  • Reverse Transcriptase Inhibitors / administration & dosage*
  • Reverse Transcriptase Inhibitors / adverse effects
  • Treatment Failure

Substances

  • Alkynes
  • Benzoxazines
  • Cyclopropanes
  • Dideoxynucleosides
  • Organophosphonates
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • Indinavir
  • Nelfinavir
  • Adenine
  • efavirenz
  • adefovir dipivoxil
  • abacavir